tiprankstipranks
Advertisement
Advertisement

ARWR Stock Latest News

Arrowhead price target raised to $123 from $101 at B. Riley
The FlyArrowhead price target raised to $123 from $101 at B. Riley
3d ago
ARWR
Arrowhead completes enrollment in Phase 3 YOSEMITE trial
PremiumThe Fly
Arrowhead completes enrollment in Phase 3 YOSEMITE trial
6d ago
ARWR
Arrowhead price target raised to $115 from $100 at H.C. Wainwright
PremiumThe Fly
Arrowhead price target raised to $115 from $100 at H.C. Wainwright
6d ago
ARWR
Arrowhead price target raised to $120 from $100 at Morgan Stanley
PremiumThe Fly
Arrowhead price target raised to $120 from $100 at Morgan Stanley
10d ago
ARWR
Arrowhead price target raised to $126 from $110 at Piper Sandler
PremiumThe Fly
Arrowhead price target raised to $126 from $110 at Piper Sandler
10d ago
ARWR
Arrowhead price target raised to $115 from $90 at Chardan
PremiumThe FlyArrowhead price target raised to $115 from $90 at Chardan
11d ago
ARWR
Arrowhead Pharmaceuticals (ARWR) Stock Soars on Strong Phase 3 Trial Results
Premium
Market News
Arrowhead Pharmaceuticals (ARWR) Stock Soars on Strong Phase 3 Trial Results
11d ago
ARWR
Arrowhead’s ARO-033 First-in-Human Trial: What Early Safety Progress Means for ARWR Investors
Premium
Company Announcements
Arrowhead’s ARO-033 First-in-Human Trial: What Early Safety Progress Means for ARWR Investors
11d ago
ARWR
Midday Fly By: AT&T reports Q2 beat, AMD invests $5B in Anthropic
PremiumThe Fly
Midday Fly By: AT&T reports Q2 beat, AMD invests $5B in Anthropic
11d ago
T
PM
Arrowhead rises 23.4%
PremiumThe Fly
Arrowhead rises 23.4%
11d ago
ARWR
Arrowhead rises 22.7%
PremiumThe Fly
Arrowhead rises 22.7%
11d ago
ARWR
Arrowhead announces Phase 3 SHASTA-3, SHASTA-4 met primary endpoint
PremiumThe Fly
Arrowhead announces Phase 3 SHASTA-3, SHASTA-4 met primary endpoint
11d ago
ARWR
Arrowhead price target raised to $95 from $88 at JPMorgan
PremiumThe FlyArrowhead price target raised to $95 from $88 at JPMorgan
16d ago
ARWR
Arrowhead initiated with a Buy at Stifel
Premium
The Fly
Arrowhead initiated with a Buy at Stifel
19d ago
ARWR
IONS
Buy Rating Reiterated on Arrowhead as Cardiometabolic RNAi Portfolio Advances; $100 Price Target Maintained
Premium
Ratings
Buy Rating Reiterated on Arrowhead as Cardiometabolic RNAi Portfolio Advances; $100 Price Target Maintained
1M ago
ARWR
Arrowhead receives MAA in the EU for REDEMPLO
PremiumThe Fly
Arrowhead receives MAA in the EU for REDEMPLO
1M ago
ARWR
Arrowhead Pharmaceuticals Adds Experienced Healthcare Investor to Board
PremiumCompany Announcements
Arrowhead Pharmaceuticals Adds Experienced Healthcare Investor to Board
2M ago
8K
ARWR
Entera Bio Is Building the Future of Peptides Beyond the Needle (NASDAQ: ENTX)
PremiumTipRanks Newswire
Entera Bio Is Building the Future of Peptides Beyond the Needle (NASDAQ: ENTX)
2M ago
NVO
ARWR
Arrowhead’s Inhaled ARO-RAGE Asthma Trial Enters Active Recruitment, Keeping a Key Pipeline Catalyst in Play
PremiumCompany Announcements
Arrowhead’s Inhaled ARO-RAGE Asthma Trial Enters Active Recruitment, Keeping a Key Pipeline Catalyst in Play
2M ago
ARWR
Arrowhead Pharmaceuticals: Buy Rating Reaffirmed as ARO-INHBE Data Strengthen Outlook and $100 Price Target Maintained
PremiumRatingsArrowhead Pharmaceuticals: Buy Rating Reaffirmed as ARO-INHBE Data Strengthen Outlook and $100 Price Target Maintained
2M ago
ARWR
Arrowhead presents interim results from Phase 1/2a trial of ARO-INHBE
Premium
The Fly
Arrowhead presents interim results from Phase 1/2a trial of ARO-INHBE
2M ago
ARWR
Arrowhead presents clinical cardiometabolic data at EAS Congress
Premium
The Fly
Arrowhead presents clinical cardiometabolic data at EAS Congress
2M ago
ARWR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >